{"ticker": {"uuid": "5f172812-7931-4290-969c-954585d5c4fc", "symbol": "LGVN", "name": "Longeveron LLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQSW9mM3I5d1lnaHgzVDlPNFgzSVg3MFNNVmk0N0hLcGh3dko0MF9kWUVzS1phTmdDU1NjUGFZamZZWTBmdnFfanllME9NWmhxd0JiMjJzM3JCQU9SVnY0cEx3T3JnT1pDUlh3Vy0xR1lDem9hZ2ZqdUFXd2UzU1JRbkczUEdHZ1hSRGdTN1JfSHgtLUxQVTBJRjNGbS15Z05pZVd0a25wZl9OX0VjNnp4WHVVOUxxeUVwbTJ1TmdMTzZvcEZVbTkzSDdEUFhvZTdtZC1fb3R2SFZ4ZzQ?oc=5", "source_name": "StockStory", "published_at": "2026-07-15T07:00:00+00:00", "published_display": "15 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Longeveron (NASDAQ: LGVN) updates CEO severance and equity vesting", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPYVpnSDRYM2NoSTRLYmdUU19aU29lemZGWm85VmgxVWpFSzFSdk9KN0lIWmNYTmlKWVl5LXBwbjAyYkxrT3pHTjAyNmExczlENklnT1UxMXRSVjliVDRfVHA5aFhkZTAtd29SWDB5SEJ6UnB4VnVQc21OeXNtYzd6U2dZeERIb0cwenZ4eWcxRnRKSjZaX3Q2cXZ0MEE3RHJDNkdrcXR3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T21:20:20+00:00", "published_display": "14 Jul 2026 21:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Inc. (LGVN) director files Form 3 showing no share holdings", "summary": "Longeveron Inc. director Arjun JJ Desai filed a Form 3, an initial insider ownership report, indicating no beneficial ownership of the company's Class A Common Stock. The filing, dated July 2, 2026, lists 0.0000 shares owned, with a clear footnote stating that no securities are b", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-3-longeveron-inc-initial-statement-of-beneficial-ownership-8aba99f4b554.html", "source_name": "Stock Titan", "published_at": "2026-07-14T22:13:18", "published_display": "14 Jul 2026 22:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Inc. (LGVN) director reports zero share ownership", "summary": "Longeveron Inc. director Deborah Ascheim filed an initial ownership report (Form 3) indicating she beneficially owns no securities of the company, specifically 0.0000 shares of Class A Common Stock. This filing establishes her starting position as zero, meaning no insider buy/sel", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-3-longeveron-inc-initial-statement-of-beneficial-ownership-773122396e60.html", "source_name": "Stock Titan", "published_at": "2026-07-14T07:10:41", "published_display": "14 Jul 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Inc. (LGVN) director Leah Cann reports no stock ownership", "summary": "Longeveron Inc. director Leah Rush Cann has filed an initial beneficial ownership report with the SEC, indicating that she holds no shares of the company's Class A Common Stock. The Form 3 filing explicitly states zero beneficial ownership, meaning she does not own any securities", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-3-longeveron-inc-initial-statement-of-beneficial-ownership-a2af48e00822.html", "source_name": "Stock Titan", "published_at": "2026-07-13T22:10:41", "published_display": "13 Jul 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer\u2019s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer\u2019s Disease", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/longeveron-announces-presentation-clinical-data-110500429.html", "source_name": "GlobeNewswire", "published_at": "2026-07-13T11:05:00+00:00", "published_display": "13 Jul 2026 11:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CSO Hare granted 600k RSUs and 400k options", "summary": "Longeveron's Chief Scientific Officer, Joshua Hare, was granted 600,000 Class B common stock shares through Restricted Stock Units (RSUs) and stock options for 400,000 Class B shares at an exercise price of $0.65. These equity awards are compensation-related and not open-market p", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-2962e6c5ffed.html", "source_name": "Stock Titan", "published_at": "2026-07-09T05:13:54", "published_display": "09 Jul 2026 05:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Longeveron LLC For: 8 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPYzNVanY3NVV4eVo3UmVvM0hYWC1keE1NdFhTZWpXSDdOc3JFSVRKNFh3NzZRS0lnMnllMHQyTlFQTUdHMmFjcU1vQUNpUkhCNk5DRDV2VXBkT3JDakZ2ckFEaXQ1cWNMRWtlWmRXc09nVW1Tb0oyV3cxdHlCM1d1WV9BajR6eGpNSFVEWmZsSXpvOVBWeGt2Ug?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-08T23:03:32+00:00", "published_display": "08 Jul 2026 23:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron grants special equity awards to Executive Chairman", "summary": "Longeveron (LGVN) has granted substantial equity awards to its Executive Chairman, including RSUs and stock options in Class B shares with enhanced voting rights. These awards, totaling 500,000 RSUs tied to recent financing, plus an additional 100,000 RSUs and 400,000 non-qualifi", "url": "https://www.tipranks.com/news/company-announcements/longeveron-grants-special-equity-awards-to-executive-chairman", "source_name": "TipRanks", "published_at": "2026-07-08T20:40:58", "published_display": "08 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) awards 600,000 RSUs and 400,000 options to Executive Chairman", "summary": "Longeveron Inc. (LGVN) has granted its Executive Chairman special equity awards consisting of 600,000 restricted stock units (RSUs) and 400,000 non-qualified stock options. These awards were given in recognition of his significant role in a March 2026 financing transaction and to", "url": "https://www.stocktitan.net/sec-filings/LGVN/8-k-longeveron-inc-reports-material-event-0fb04254c4eb.html", "source_name": "Stock Titan", "published_at": "2026-07-08T19:40:57", "published_display": "08 Jul 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron strengthens financial leadership with new CFO appointment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxPWjQ0VDhvNTdLakN3cndQMi0xd2t4dFRhdFQ2NV9SWlFuRjdYUENBRHF5LUlFVkJRdHF2b0J4MG1jekZJX2VvdDVfYmtib2pKSkRPc3JubkRlczJ6OXNHYm1QVHIxOXFWa0U3eF9UUHpDVUFOaFZJUmo3VkNHZGdkeTFzbmRVSlFqVVFsTW1taDY0QkdFXzdIYmdWdXI3Ql82ZkZmU004bTdjcXNZVGdRNldUVk9ldFQwRVJsal9xVm1UM2VQWnZjNFQzNHNSeTM0VmZ2cGpQd19yUVNsSEhyQmZBUzR1UTl0T1pF?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-07T21:38:00+00:00", "published_display": "07 Jul 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Longeveron LLC For: 6 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOWnpTWGFESWhTdVdFNmZiSnFZX3JXNTFSaVRUOThIMWM5UWpHM2o3YTcwUnhOZDdsblYzZGxTanlSVlNqaXlWcGt6UXdFZzVIRlZ6dEQzUEF6S21BOFpaZ18yQW1ySVJqcFNvY2dYTHQ1NVFuTnZ2bnN0RjJkZGtDSnd1aGJFQm5fX29LdUlGa01BQzJKbl9KRA?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T01:36:49+00:00", "published_display": "07 Jul 2026 01:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (NASDAQ: LGVN) CTO has 15,808 shares withheld for taxes", "summary": "Longeveron Inc.'s CTO, Devin Blass, had 15,808 shares of Class A Common Stock withheld at $0.7291 per share to cover tax obligations related to the vesting of restricted stock units (RSUs). This was a routine, non-market transaction, categorized as an \"F\" code transaction in the ", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-76a4eaec5aed.html", "source_name": "Stock Titan", "published_at": "2026-07-07T00:41:05", "published_display": "07 Jul 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) counsel reports RSU tax-withholding share disposition", "summary": "Longeveron Inc.'s General Counsel and Secretary, Paul T. Lehr, reported a routine disposition of 13,143 Class A Common Stock shares on July 1, 2026. These shares, valued at $0.7291 each, were withheld to cover tax obligations arising from a restricted stock unit (RSU) award vesti", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-0c590efc258e.html", "source_name": "Stock Titan", "published_at": "2026-07-07T00:41:05", "published_display": "07 Jul 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CFO has shares withheld to cover RSU tax obligations", "summary": "Longeveron Inc.'s CFO, Lisa Locklear, reported a tax-related disposition where 22,505 shares of Class A Common Stock were withheld at $0.7291 per share to satisfy tax obligations upon the vesting of a restricted stock unit (RSU) award. This was an automatic tax-withholding mechan", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-631e2d3dfc7d.html", "source_name": "Stock Titan", "published_at": "2026-07-07T00:41:05", "published_display": "07 Jul 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CMO reports 22,505-share tax withholding after RSU vesting", "summary": "Longeveron Inc.'s Chief Medical Officer, Nataliya Agafonova, reported a tax-related share disposition where 22,505 shares of Class A Common Stock were withheld at $0.7291 per share to cover tax obligations from the vesting of a restricted stock unit (RSU) award. Following this tr", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-c08c8634a0e0.html", "source_name": "Stock Titan", "published_at": "2026-07-07T00:41:05", "published_display": "07 Jul 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CEO has 18,046 shares withheld to cover RSU tax obligations", "summary": "Longeveron Inc.'s CEO, Willard Stephen H, reported a tax-related share disposition where 18,046 shares of Class A Common Stock were withheld at $0.7291 per share to cover tax obligations from a restricted stock unit (RSU) vesting on July 1, 2026. This transaction was a tax paymen", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-0211158f37a6.html", "source_name": "Stock Titan", "published_at": "2026-07-07T00:41:05", "published_display": "07 Jul 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Names Marie Washburn as CFO", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/longeveron-names-marie-washburn-cfo-202457684.html", "source_name": "MT Newswires", "published_at": "2026-07-06T20:24:57+00:00", "published_display": "06 Jul 2026 20:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron\u00ae Appoints Marie Washburn as Chief Financial Officer", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/longeveron-appoints-marie-washburn-chief-200500338.html", "source_name": "GlobeNewswire", "published_at": "2026-07-06T20:05:00+00:00", "published_display": "06 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron taps Marie Washburn as CFO ahead of July trial readout", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQczUxQm9UUzhmM2JpZjFlOE5welNlb09vX3c0c0dIRTJsMnI1Tl9aQzJfSkpVTG5fV0ZoYVNDZll0S2ItbTRuMnZsWkJiNnhMRTNFT0JqYlNHVEExR3pXR09oYlZPNVE0ZkxxdFY3NElKQzhWWVNNblBjMTNfUEEyTjFYSm1EbUdfa1pEQ2FWQzJRYzdHMGc5SXB4MUsxUU5mT2NZM0RVang4N1Rv?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Inc. Class A Actuals & Estimates (NASDAQ:LGVN)", "summary": "This article provides an overview of Longeveron Inc. (NASDAQ: LGVN) stock, including its current price, market capitalization, and analyst forecasts. It also details recent financial performance, such as earnings and revenue, and answers frequently asked questions about the compa", "url": "https://www.tradingview.com/symbols/NASDAQ-LGVN/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T13:11:30", "published_display": "26 Jun 2026 13:11", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Granted SME Status by European Medicines Agency", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/longeveron-granted-sme-status-european-135245561.html", "source_name": "MT Newswires", "published_at": "2026-06-09T13:52:45+00:00", "published_display": "09 Jun 2026 13:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA)", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/longeveron-granted-small-medium-sized-132000716.html", "source_name": "GlobeNewswire", "published_at": "2026-06-09T13:20:00+00:00", "published_display": "09 Jun 2026 13:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron to Present at BIO International Convention 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/longeveron-present-bio-international-convention-131500624.html", "source_name": "GlobeNewswire", "published_at": "2026-06-04T13:15:00+00:00", "published_display": "04 Jun 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/longeveron-issues-letter-stockholders-highlighting-200500531.html", "source_name": "GlobeNewswire", "published_at": "2026-05-20T20:05:00+00:00", "published_display": "20 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[SCHEDULE 13G] Longeveron Inc. Passive Investment Disclosure (>5%)", "summary": "Janus Henderson Group plc has filed a Schedule 13G, disclosing a passive investment of 1,291,331 shares in Longeveron Inc. (LGVN). This represents 5.9% of Longeveron's Class A Common Stock as of March 31, 2026. The shares are held by Janus Henderson's Asset Managers in various ma", "url": "https://www.stocktitan.net/sec-filings/LGVN/schedule-13g-longeveron-inc-passive-investment-disclosure-5-b5906fc625d2.html", "source_name": "Stock Titan", "published_at": "2026-05-15T15:38:46", "published_display": "15 May 2026 15:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Longeveron Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/310fe5af-6731-3eb9-a0ab-16c1d06c6116/longeveron-inc.-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-14T12:30:00+00:00", "published_display": "14 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Inc. - Class A Common stock (NQ: LGVN)", "summary": "This article compiles recent news and financial updates concerning Longeveron Inc. (NASDAQ: LGVN). It includes reports on their Q1 earnings, partnerships with the US Department of Veterans Affairs for Alzheimer's trials, short interest analysis, and mentions of the stock in broad", "url": "https://markets.financialcontent.com/stocks/quote/news?Symbol=NQ%3ALGVN&CurrentPage=10", "source_name": "FinancialContent", "published_at": "2026-05-14T09:09:09", "published_display": "14 May 2026 09:09", "sentiment": "negative", "sentiment_pct": 33, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Longeveron to Report 2026 First Quarter Financial Results and Host Conference Call on May 13, 2026", "summary": "Longeveron Inc. (NASDAQ: LGVN), a biotechnology company, has announced that it will release its 2026 first quarter financial results and provide a business update on May 13, 2026, after the U.S. financial markets close. The company will also host a conference call and webcast on ", "url": "https://www.manilatimes.net/2026/05/06/tmt-newswire/globenewswire/longeveron-to-report-2026-first-quarter-financial-results-and-host-conference-call-on-may-13-2026/2336593/amp", "source_name": "The Manila Times", "published_at": "2026-05-06T04:26:00", "published_display": "06 May 2026 04:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (NASDAQ: LGVN) CEO receives 500,000 RSUs grant", "summary": "Longeveron Inc. CEO Willard Stephen H was granted 500,000 time-based vesting Restricted Stock Units (RSUs) of Class A Common Stock on May 1, 2026, as reported in a Form 4 SEC filing. This equity compensation award, granted at $0.00 per share, increases his direct holdings to 789,", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-b79f2143ba2d.html", "source_name": "Stock Titan", "published_at": "2026-05-06T00:38:44", "published_display": "06 May 2026 00:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CTO Devin Blass receives 250,000 RSU share award", "summary": "Longeveron Inc. (LGVN) CTO and SVP of CMC, Devin Blass, was granted 250,000 Restricted Stock Units (RSUs) of Class A Common Stock. This award, which vests over time, increases his total direct holdings to 441,543 shares. The RSUs were awarded at a price of $0.0000 per share as co", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-738358e3e147.html", "source_name": "Stock Titan", "published_at": "2026-05-05T21:38:44", "published_display": "05 May 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (NASDAQ: LGVN) grants CMO 250,000 time-based RSUs", "summary": "Longeveron Inc. (NASDAQ: LGVN) reported that its Chief Medical Officer, Nataliya Agafonova, received an award of 250,000 time-based vesting Restricted Stock Units (RSUs) of Class A Common Stock on May 1, 2026, with a stated price of $0.00 per share. This non-cash equity grant inc", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-99a16a36f667.html", "source_name": "Stock Titan", "published_at": "2026-05-05T21:38:44", "published_display": "05 May 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CFO awarded 250,000 RSUs of Class A stock", "summary": "Longeveron Inc. (LGVN) CFO Lisa Locklear was granted 250,000 shares of Class A Common Stock as time-based vesting Restricted Stock Units (RSUs) on May 1, 2026. This award, valued at $0.00 per share as a compensation award, increases Locklear's direct holdings to 465,686 shares, i", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-e47b95bf6a5f.html", "source_name": "Stock Titan", "published_at": "2026-05-05T21:38:44", "published_display": "05 May 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) General Counsel receives 250,000-share RSU equity grant", "summary": "Longeveron Inc.'s General Counsel and Secretary, Paul T. Lehr, received a grant of 250,000 shares of Class A common stock in the form of time-based vesting Restricted Stock Units (RSUs). This award increases his total reported holdings to 588,566 shares, encompassing RSUs subject", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-9af0f16aa147.html", "source_name": "Stock Titan", "published_at": "2026-05-05T21:38:44", "published_display": "05 May 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "30.9M Longeveron shares registered for resale (NASDAQ: LGVN)", "summary": "Longeveron Inc. has registered 30.9 million Class A common shares for resale by existing stockholders following a private placement. The company will not receive proceeds from these resales, with the exception of potential funds from the exercise of placement agent warrants. This", "url": "https://www.stocktitan.net/sec-filings/LGVN/424b3-longeveron-inc-prospectus-filed-pursuant-to-rule-424-b-3-e1153ca0e929.html", "source_name": "Stock Titan", "published_at": "2026-04-17T20:09:42", "published_display": "17 Apr 2026 20:09", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (NASDAQ: LGVN) resale filing details 30.9M registered shares", "summary": "Longeveron (NASDAQ: LGVN) has filed an S-1 registration statement for the resale of 30.9 million Class A common stock shares by existing investors. The company will not receive proceeds from these resales, except for potential funds from the exercise of placement agent warrants. ", "url": "https://www.stocktitan.net/sec-filings/LGVN/s-1-longeveron-inc-files-ipo-registration-statement-a3595e6aa0bf.html", "source_name": "Stock Titan", "published_at": "2026-04-10T20:10:12", "published_display": "10 Apr 2026 20:10", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CMO has shares withheld to cover RSU tax obligations", "summary": "Longeveron Inc.'s Chief Medical Officer, Nataliya Agafonova, had 13,145 shares of Class A common stock withheld to satisfy tax obligations upon the vesting of a restricted stock unit award. This transaction, priced at $1.12 per share, is a routine tax-related disposition and not ", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-8a16e1d7260e.html", "source_name": "Stock Titan", "published_at": "2026-04-03T21:10:22", "published_display": "03 Apr 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CFO has 13,145 shares withheld to cover RSU tax", "summary": "Longeveron Inc.'s CFO, Lisa Locklear, had 13,145 shares of Class A Common Stock withheld at $1.12 per share on April 1, 2026, to satisfy tax obligations related to the vesting of a restricted stock unit (RSU) award. This transaction was a routine tax-withholding disposition, not ", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-45719efc6977.html", "source_name": "Stock Titan", "published_at": "2026-04-03T21:10:22", "published_display": "03 Apr 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] Longeveron Inc. Insider Trading Activity", "summary": "Longeveron Inc. General Counsel and Secretary Paul T. Lehr reported a tax-related disposition of 5,611 shares of Class A common stock at $1.12 per share to cover tax obligations stemming from a restricted stock unit award vesting. Following this transaction, Lehr directly holds 3", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-4ed3ce655014.html", "source_name": "Stock Titan", "published_at": "2026-04-03T21:10:22", "published_display": "03 Apr 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CEO has shares withheld to cover RSU tax bill", "summary": "Longeveron Inc. CEO Willard Stephen H reported a routine tax-related share transaction where 4,740 shares of Class A Common Stock were withheld at $1.12 per share to satisfy tax obligations upon the vesting of Restricted Stock Units (RSUs). This mechanism prevented an open-market", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-faa9b7974823.html", "source_name": "Stock Titan", "published_at": "2026-04-03T21:10:22", "published_display": "03 Apr 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Longeveron Receives Extended Nasdaq Compliance Grace Period", "summary": "Longeveron Inc. (LGVN) has been granted an extended grace period by Nasdaq until September 21, 2026, to regain compliance with the minimum $1.00 bid price rule, avoiding immediate delisting. This extension provides the company more time to monitor its share price and consider opt", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/992334/longeveron-receives-extended-nasdaq-compliance-grace-period/", "source_name": "The Globe and Mail", "published_at": "2026-03-27T03:40:08", "published_display": "27 Mar 2026 03:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (NASDAQ: LGVN) granted more time to cure Nasdaq $1 bid rule", "summary": "Longeveron Inc. (NASDAQ: LGVN) has been granted an additional 180-day extension by Nasdaq, until September 21, 2026, to regain compliance with the minimum $1.00 bid price requirement for its Class A common stock. The company originally received a noncompliance notice on September", "url": "https://www.stocktitan.net/sec-filings/LGVN/8-k-longeveron-inc-reports-material-event-1813bb932a2b.html", "source_name": "Stock Titan", "published_at": "2026-03-25T20:09:14", "published_display": "25 Mar 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LONGEVERON ($LGVN) Releases Q4 2025 Earnings, Stock Rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQUDRvOW9wM01fMGdsWnFOQzNhUDdWLUVESUxLWmVpUlppaXRfZ3VibUVvcEFfTHJWRDNKUUdRZlh3alBYWi1VbE9MZjdkVGkxbW9FRHhfbGF1VjZWajZqcFFHcmNFb1NDZUhyc25YazFIb0dCbjhVR2hlRDBVdjdkT0RobnQySWM0NGRKamdYQThPa3gtdEJyVnliR0RPaFU?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings To Watch: Longeveron Inc (LGVN) Reports Q4 2025 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNYmlEVHBFVHl2T2ZCWFFlYWNwVlhJZkl3UWJDNnFUV3FTdjFzWGNHd05hLTZFM1Y2bWRPN096aTRGb2prUUpmNmM2QVRMLXhSQTdrYy1qVVVwMmVXY1BkendfSW1RQUxLUGk0TlNIa3dKNjRPV0EwUXMzZEc5QXh1TzdDdjFVNFE?oc=5", "source_name": "Market source", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Announces Private Placement of up to $30 Million", "summary": "Longeveron Inc. (NASDAQ: LGVN) announced a private placement targeting up to $30 million in gross proceeds, led by Coastlands Capital and including Janus Henderson Investors. An initial $15 million will extend the company's cash runway into Q4 2026, past the anticipated Q3 2026 t", "url": "https://www.globenewswire.com/news-release/2026/03/10/3252938/0/en/Longeveron-Announces-Private-Placement-of-up-to-30-Million.html", "source_name": "GlobeNewswire", "published_at": "2026-03-14T23:09:58", "published_display": "14 Mar 2026 23:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A $30 Million Reason to Buy Penny Stock Longeveron Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQc0pkeWVRTy1TMG5jUlZsUk9RQXdWRzN2QzkySTVtQ1NZR2xNN3FSQVoySTdJbWtvQ3NzbVlrenEzV1dXMHR0d1pRb0NScDNGZC00ZVNHNkVnRkNqSU0yX0c3ck1lVHpzcmNadWNVM0ZMcnZ3NU00SG5HbUI5UXlBbG9oa2ttMHdKTlRsemVnU1kxMzdTdVJLc0xtRlBhOHc?oc=5", "source_name": "Barchart.com", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron secures $15M financing, eyes $15M more on trial results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOdjV1Y09XY0pxdUJqbnFORGtBazJXcXVGenEzdWtPZVEyMjV5bFZYd0VkbVdGSzRWMU02c0ZEUERNWm1TclI3bkJaQ0JTc0tUSDF4ZnpaVGZhTkhJckgtRWpEdEFVaFg5aHQ5c1BsTnZtQVhWRFpWcnRUVGZYX1ZucWc3cFM0YUVFQVJRODBUSlVVQVZMVXZTaFJrSHpJSkxiSjFhdTViSFI4RUw2NVB5MmxrX0hscjZDMnJQWg?oc=5", "source_name": "Investing.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron secures $15M now, another $15M tied to HLHS trial milestones", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQbVJoS20tcUhMc2N1aDBYTVp0WnVDOUZ0ZUo4bjFTRlJoODFUY20zdDMxLXZ6LTZEM1ZIRk9ub2NucGhFVDJmOXFmTFFaVXA0dFdieXM5ajJiOUhmSnhnbTh5NERaOVVGTUV1UTFkakVQSkZrQVc5bUpldm4zRzhZdTVmd0VjV29mbXV2Nms4dmFycHJDeU5YX2t2RGhDblBJY3VPNjR4V20?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Longeveron (NASDAQ: LGVN) updates CEO severance and equity vesting", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPYVpnSDRYM2NoSTRLYmdUU19aU29lemZGWm85VmgxVWpFSzFSdk9KN0lIWmNYTmlKWVl5LXBwbjAyYkxrT3pHTjAyNmExczlENklnT1UxMXRSVjliVDRfVHA5aFhkZTAtd29SWDB5SEJ6UnB4VnVQc21OeXNtYzd6U2dZeERIb0cwenZ4eWcxRnRKSjZaX3Q2cXZ0MEE3RHJDNkdrcXR3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T21:20:20+00:00", "published_display": "14 Jul 2026 21:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Inc. (LGVN) director files Form 3 showing no share holdings", "summary": "Longeveron Inc. director Arjun JJ Desai filed a Form 3, an initial insider ownership report, indicating no beneficial ownership of the company's Class A Common Stock. The filing, dated July 2, 2026, lists 0.0000 shares owned, with a clear footnote stating that no securities are b", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-3-longeveron-inc-initial-statement-of-beneficial-ownership-8aba99f4b554.html", "source_name": "Stock Titan", "published_at": "2026-07-14T22:13:18", "published_display": "14 Jul 2026 22:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Inc. (LGVN) director reports zero share ownership", "summary": "Longeveron Inc. director Deborah Ascheim filed an initial ownership report (Form 3) indicating she beneficially owns no securities of the company, specifically 0.0000 shares of Class A Common Stock. This filing establishes her starting position as zero, meaning no insider buy/sel", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-3-longeveron-inc-initial-statement-of-beneficial-ownership-773122396e60.html", "source_name": "Stock Titan", "published_at": "2026-07-14T07:10:41", "published_display": "14 Jul 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Inc. (LGVN) director Leah Cann reports no stock ownership", "summary": "Longeveron Inc. director Leah Rush Cann has filed an initial beneficial ownership report with the SEC, indicating that she holds no shares of the company's Class A Common Stock. The Form 3 filing explicitly states zero beneficial ownership, meaning she does not own any securities", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-3-longeveron-inc-initial-statement-of-beneficial-ownership-a2af48e00822.html", "source_name": "Stock Titan", "published_at": "2026-07-13T22:10:41", "published_display": "13 Jul 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer\u2019s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer\u2019s Disease", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/longeveron-announces-presentation-clinical-data-110500429.html", "source_name": "GlobeNewswire", "published_at": "2026-07-13T11:05:00+00:00", "published_display": "13 Jul 2026 11:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CSO Hare granted 600k RSUs and 400k options", "summary": "Longeveron's Chief Scientific Officer, Joshua Hare, was granted 600,000 Class B common stock shares through Restricted Stock Units (RSUs) and stock options for 400,000 Class B shares at an exercise price of $0.65. These equity awards are compensation-related and not open-market p", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-2962e6c5ffed.html", "source_name": "Stock Titan", "published_at": "2026-07-09T05:13:54", "published_display": "09 Jul 2026 05:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Longeveron LLC For: 8 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPYzNVanY3NVV4eVo3UmVvM0hYWC1keE1NdFhTZWpXSDdOc3JFSVRKNFh3NzZRS0lnMnllMHQyTlFQTUdHMmFjcU1vQUNpUkhCNk5DRDV2VXBkT3JDakZ2ckFEaXQ1cWNMRWtlWmRXc09nVW1Tb0oyV3cxdHlCM1d1WV9BajR6eGpNSFVEWmZsSXpvOVBWeGt2Ug?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-08T23:03:32+00:00", "published_display": "08 Jul 2026 23:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron grants special equity awards to Executive Chairman", "summary": "Longeveron (LGVN) has granted substantial equity awards to its Executive Chairman, including RSUs and stock options in Class B shares with enhanced voting rights. These awards, totaling 500,000 RSUs tied to recent financing, plus an additional 100,000 RSUs and 400,000 non-qualifi", "url": "https://www.tipranks.com/news/company-announcements/longeveron-grants-special-equity-awards-to-executive-chairman", "source_name": "TipRanks", "published_at": "2026-07-08T20:40:58", "published_display": "08 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) awards 600,000 RSUs and 400,000 options to Executive Chairman", "summary": "Longeveron Inc. (LGVN) has granted its Executive Chairman special equity awards consisting of 600,000 restricted stock units (RSUs) and 400,000 non-qualified stock options. These awards were given in recognition of his significant role in a March 2026 financing transaction and to", "url": "https://www.stocktitan.net/sec-filings/LGVN/8-k-longeveron-inc-reports-material-event-0fb04254c4eb.html", "source_name": "Stock Titan", "published_at": "2026-07-08T19:40:57", "published_display": "08 Jul 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron strengthens financial leadership with new CFO appointment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxPWjQ0VDhvNTdLakN3cndQMi0xd2t4dFRhdFQ2NV9SWlFuRjdYUENBRHF5LUlFVkJRdHF2b0J4MG1jekZJX2VvdDVfYmtib2pKSkRPc3JubkRlczJ6OXNHYm1QVHIxOXFWa0U3eF9UUHpDVUFOaFZJUmo3VkNHZGdkeTFzbmRVSlFqVVFsTW1taDY0QkdFXzdIYmdWdXI3Ql82ZkZmU004bTdjcXNZVGdRNldUVk9ldFQwRVJsal9xVm1UM2VQWnZjNFQzNHNSeTM0VmZ2cGpQd19yUVNsSEhyQmZBUzR1UTl0T1pF?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-07T21:38:00+00:00", "published_display": "07 Jul 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Longeveron LLC For: 6 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOWnpTWGFESWhTdVdFNmZiSnFZX3JXNTFSaVRUOThIMWM5UWpHM2o3YTcwUnhOZDdsblYzZGxTanlSVlNqaXlWcGt6UXdFZzVIRlZ6dEQzUEF6S21BOFpaZ18yQW1ySVJqcFNvY2dYTHQ1NVFuTnZ2bnN0RjJkZGtDSnd1aGJFQm5fX29LdUlGa01BQzJKbl9KRA?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T01:36:49+00:00", "published_display": "07 Jul 2026 01:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (NASDAQ: LGVN) CTO has 15,808 shares withheld for taxes", "summary": "Longeveron Inc.'s CTO, Devin Blass, had 15,808 shares of Class A Common Stock withheld at $0.7291 per share to cover tax obligations related to the vesting of restricted stock units (RSUs). This was a routine, non-market transaction, categorized as an \"F\" code transaction in the ", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-76a4eaec5aed.html", "source_name": "Stock Titan", "published_at": "2026-07-07T00:41:05", "published_display": "07 Jul 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) counsel reports RSU tax-withholding share disposition", "summary": "Longeveron Inc.'s General Counsel and Secretary, Paul T. Lehr, reported a routine disposition of 13,143 Class A Common Stock shares on July 1, 2026. These shares, valued at $0.7291 each, were withheld to cover tax obligations arising from a restricted stock unit (RSU) award vesti", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-0c590efc258e.html", "source_name": "Stock Titan", "published_at": "2026-07-07T00:41:05", "published_display": "07 Jul 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CFO has shares withheld to cover RSU tax obligations", "summary": "Longeveron Inc.'s CFO, Lisa Locklear, reported a tax-related disposition where 22,505 shares of Class A Common Stock were withheld at $0.7291 per share to satisfy tax obligations upon the vesting of a restricted stock unit (RSU) award. This was an automatic tax-withholding mechan", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-631e2d3dfc7d.html", "source_name": "Stock Titan", "published_at": "2026-07-07T00:41:05", "published_display": "07 Jul 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CMO reports 22,505-share tax withholding after RSU vesting", "summary": "Longeveron Inc.'s Chief Medical Officer, Nataliya Agafonova, reported a tax-related share disposition where 22,505 shares of Class A Common Stock were withheld at $0.7291 per share to cover tax obligations from the vesting of a restricted stock unit (RSU) award. Following this tr", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-c08c8634a0e0.html", "source_name": "Stock Titan", "published_at": "2026-07-07T00:41:05", "published_display": "07 Jul 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CEO has 18,046 shares withheld to cover RSU tax obligations", "summary": "Longeveron Inc.'s CEO, Willard Stephen H, reported a tax-related share disposition where 18,046 shares of Class A Common Stock were withheld at $0.7291 per share to cover tax obligations from a restricted stock unit (RSU) vesting on July 1, 2026. This transaction was a tax paymen", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-0211158f37a6.html", "source_name": "Stock Titan", "published_at": "2026-07-07T00:41:05", "published_display": "07 Jul 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Names Marie Washburn as CFO", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/longeveron-names-marie-washburn-cfo-202457684.html", "source_name": "MT Newswires", "published_at": "2026-07-06T20:24:57+00:00", "published_display": "06 Jul 2026 20:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron\u00ae Appoints Marie Washburn as Chief Financial Officer", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/longeveron-appoints-marie-washburn-chief-200500338.html", "source_name": "GlobeNewswire", "published_at": "2026-07-06T20:05:00+00:00", "published_display": "06 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron taps Marie Washburn as CFO ahead of July trial readout", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQczUxQm9UUzhmM2JpZjFlOE5welNlb09vX3c0c0dIRTJsMnI1Tl9aQzJfSkpVTG5fV0ZoYVNDZll0S2ItbTRuMnZsWkJiNnhMRTNFT0JqYlNHVEExR3pXR09oYlZPNVE0ZkxxdFY3NElKQzhWWVNNblBjMTNfUEEyTjFYSm1EbUdfa1pEQ2FWQzJRYzdHMGc5SXB4MUsxUU5mT2NZM0RVang4N1Rv?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Inc. Class A Actuals & Estimates (NASDAQ:LGVN)", "summary": "This article provides an overview of Longeveron Inc. (NASDAQ: LGVN) stock, including its current price, market capitalization, and analyst forecasts. It also details recent financial performance, such as earnings and revenue, and answers frequently asked questions about the compa", "url": "https://www.tradingview.com/symbols/NASDAQ-LGVN/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T13:11:30", "published_display": "26 Jun 2026 13:11", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Granted SME Status by European Medicines Agency", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/longeveron-granted-sme-status-european-135245561.html", "source_name": "MT Newswires", "published_at": "2026-06-09T13:52:45+00:00", "published_display": "09 Jun 2026 13:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA)", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/longeveron-granted-small-medium-sized-132000716.html", "source_name": "GlobeNewswire", "published_at": "2026-06-09T13:20:00+00:00", "published_display": "09 Jun 2026 13:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron to Present at BIO International Convention 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/longeveron-present-bio-international-convention-131500624.html", "source_name": "GlobeNewswire", "published_at": "2026-06-04T13:15:00+00:00", "published_display": "04 Jun 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/longeveron-issues-letter-stockholders-highlighting-200500531.html", "source_name": "GlobeNewswire", "published_at": "2026-05-20T20:05:00+00:00", "published_display": "20 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[SCHEDULE 13G] Longeveron Inc. Passive Investment Disclosure (>5%)", "summary": "Janus Henderson Group plc has filed a Schedule 13G, disclosing a passive investment of 1,291,331 shares in Longeveron Inc. (LGVN). This represents 5.9% of Longeveron's Class A Common Stock as of March 31, 2026. The shares are held by Janus Henderson's Asset Managers in various ma", "url": "https://www.stocktitan.net/sec-filings/LGVN/schedule-13g-longeveron-inc-passive-investment-disclosure-5-b5906fc625d2.html", "source_name": "Stock Titan", "published_at": "2026-05-15T15:38:46", "published_display": "15 May 2026 15:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/310fe5af-6731-3eb9-a0ab-16c1d06c6116/longeveron-inc.-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-14T12:30:00+00:00", "published_display": "14 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Inc. - Class A Common stock (NQ: LGVN)", "summary": "This article compiles recent news and financial updates concerning Longeveron Inc. (NASDAQ: LGVN). It includes reports on their Q1 earnings, partnerships with the US Department of Veterans Affairs for Alzheimer's trials, short interest analysis, and mentions of the stock in broad", "url": "https://markets.financialcontent.com/stocks/quote/news?Symbol=NQ%3ALGVN&CurrentPage=10", "source_name": "FinancialContent", "published_at": "2026-05-14T09:09:09", "published_display": "14 May 2026 09:09", "sentiment": "negative", "sentiment_pct": 33, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron to Report 2026 First Quarter Financial Results and Host Conference Call on May 13, 2026", "summary": "Longeveron Inc. (NASDAQ: LGVN), a biotechnology company, has announced that it will release its 2026 first quarter financial results and provide a business update on May 13, 2026, after the U.S. financial markets close. The company will also host a conference call and webcast on ", "url": "https://www.manilatimes.net/2026/05/06/tmt-newswire/globenewswire/longeveron-to-report-2026-first-quarter-financial-results-and-host-conference-call-on-may-13-2026/2336593/amp", "source_name": "The Manila Times", "published_at": "2026-05-06T04:26:00", "published_display": "06 May 2026 04:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (NASDAQ: LGVN) CEO receives 500,000 RSUs grant", "summary": "Longeveron Inc. CEO Willard Stephen H was granted 500,000 time-based vesting Restricted Stock Units (RSUs) of Class A Common Stock on May 1, 2026, as reported in a Form 4 SEC filing. This equity compensation award, granted at $0.00 per share, increases his direct holdings to 789,", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-b79f2143ba2d.html", "source_name": "Stock Titan", "published_at": "2026-05-06T00:38:44", "published_display": "06 May 2026 00:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CTO Devin Blass receives 250,000 RSU share award", "summary": "Longeveron Inc. (LGVN) CTO and SVP of CMC, Devin Blass, was granted 250,000 Restricted Stock Units (RSUs) of Class A Common Stock. This award, which vests over time, increases his total direct holdings to 441,543 shares. The RSUs were awarded at a price of $0.0000 per share as co", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-738358e3e147.html", "source_name": "Stock Titan", "published_at": "2026-05-05T21:38:44", "published_display": "05 May 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (NASDAQ: LGVN) grants CMO 250,000 time-based RSUs", "summary": "Longeveron Inc. (NASDAQ: LGVN) reported that its Chief Medical Officer, Nataliya Agafonova, received an award of 250,000 time-based vesting Restricted Stock Units (RSUs) of Class A Common Stock on May 1, 2026, with a stated price of $0.00 per share. This non-cash equity grant inc", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-99a16a36f667.html", "source_name": "Stock Titan", "published_at": "2026-05-05T21:38:44", "published_display": "05 May 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CFO awarded 250,000 RSUs of Class A stock", "summary": "Longeveron Inc. (LGVN) CFO Lisa Locklear was granted 250,000 shares of Class A Common Stock as time-based vesting Restricted Stock Units (RSUs) on May 1, 2026. This award, valued at $0.00 per share as a compensation award, increases Locklear's direct holdings to 465,686 shares, i", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-e47b95bf6a5f.html", "source_name": "Stock Titan", "published_at": "2026-05-05T21:38:44", "published_display": "05 May 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) General Counsel receives 250,000-share RSU equity grant", "summary": "Longeveron Inc.'s General Counsel and Secretary, Paul T. Lehr, received a grant of 250,000 shares of Class A common stock in the form of time-based vesting Restricted Stock Units (RSUs). This award increases his total reported holdings to 588,566 shares, encompassing RSUs subject", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-9af0f16aa147.html", "source_name": "Stock Titan", "published_at": "2026-05-05T21:38:44", "published_display": "05 May 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "30.9M Longeveron shares registered for resale (NASDAQ: LGVN)", "summary": "Longeveron Inc. has registered 30.9 million Class A common shares for resale by existing stockholders following a private placement. The company will not receive proceeds from these resales, with the exception of potential funds from the exercise of placement agent warrants. This", "url": "https://www.stocktitan.net/sec-filings/LGVN/424b3-longeveron-inc-prospectus-filed-pursuant-to-rule-424-b-3-e1153ca0e929.html", "source_name": "Stock Titan", "published_at": "2026-04-17T20:09:42", "published_display": "17 Apr 2026 20:09", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (NASDAQ: LGVN) resale filing details 30.9M registered shares", "summary": "Longeveron (NASDAQ: LGVN) has filed an S-1 registration statement for the resale of 30.9 million Class A common stock shares by existing investors. The company will not receive proceeds from these resales, except for potential funds from the exercise of placement agent warrants. ", "url": "https://www.stocktitan.net/sec-filings/LGVN/s-1-longeveron-inc-files-ipo-registration-statement-a3595e6aa0bf.html", "source_name": "Stock Titan", "published_at": "2026-04-10T20:10:12", "published_display": "10 Apr 2026 20:10", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CMO has shares withheld to cover RSU tax obligations", "summary": "Longeveron Inc.'s Chief Medical Officer, Nataliya Agafonova, had 13,145 shares of Class A common stock withheld to satisfy tax obligations upon the vesting of a restricted stock unit award. This transaction, priced at $1.12 per share, is a routine tax-related disposition and not ", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-8a16e1d7260e.html", "source_name": "Stock Titan", "published_at": "2026-04-03T21:10:22", "published_display": "03 Apr 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CFO has 13,145 shares withheld to cover RSU tax", "summary": "Longeveron Inc.'s CFO, Lisa Locklear, had 13,145 shares of Class A Common Stock withheld at $1.12 per share on April 1, 2026, to satisfy tax obligations related to the vesting of a restricted stock unit (RSU) award. This transaction was a routine tax-withholding disposition, not ", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-45719efc6977.html", "source_name": "Stock Titan", "published_at": "2026-04-03T21:10:22", "published_display": "03 Apr 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] Longeveron Inc. Insider Trading Activity", "summary": "Longeveron Inc. General Counsel and Secretary Paul T. Lehr reported a tax-related disposition of 5,611 shares of Class A common stock at $1.12 per share to cover tax obligations stemming from a restricted stock unit award vesting. Following this transaction, Lehr directly holds 3", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-4ed3ce655014.html", "source_name": "Stock Titan", "published_at": "2026-04-03T21:10:22", "published_display": "03 Apr 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (LGVN) CEO has shares withheld to cover RSU tax bill", "summary": "Longeveron Inc. CEO Willard Stephen H reported a routine tax-related share transaction where 4,740 shares of Class A Common Stock were withheld at $1.12 per share to satisfy tax obligations upon the vesting of Restricted Stock Units (RSUs). This mechanism prevented an open-market", "url": "https://www.stocktitan.net/sec-filings/LGVN/form-4-longeveron-inc-insider-trading-activity-faa9b7974823.html", "source_name": "Stock Titan", "published_at": "2026-04-03T21:10:22", "published_display": "03 Apr 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Receives Extended Nasdaq Compliance Grace Period", "summary": "Longeveron Inc. (LGVN) has been granted an extended grace period by Nasdaq until September 21, 2026, to regain compliance with the minimum $1.00 bid price rule, avoiding immediate delisting. This extension provides the company more time to monitor its share price and consider opt", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/992334/longeveron-receives-extended-nasdaq-compliance-grace-period/", "source_name": "The Globe and Mail", "published_at": "2026-03-27T03:40:08", "published_display": "27 Mar 2026 03:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron (NASDAQ: LGVN) granted more time to cure Nasdaq $1 bid rule", "summary": "Longeveron Inc. (NASDAQ: LGVN) has been granted an additional 180-day extension by Nasdaq, until September 21, 2026, to regain compliance with the minimum $1.00 bid price requirement for its Class A common stock. The company originally received a noncompliance notice on September", "url": "https://www.stocktitan.net/sec-filings/LGVN/8-k-longeveron-inc-reports-material-event-1813bb932a2b.html", "source_name": "Stock Titan", "published_at": "2026-03-25T20:09:14", "published_display": "25 Mar 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LONGEVERON ($LGVN) Releases Q4 2025 Earnings, Stock Rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQUDRvOW9wM01fMGdsWnFOQzNhUDdWLUVESUxLWmVpUlppaXRfZ3VibUVvcEFfTHJWRDNKUUdRZlh3alBYWi1VbE9MZjdkVGkxbW9FRHhfbGF1VjZWajZqcFFHcmNFb1NDZUhyc25YazFIb0dCbjhVR2hlRDBVdjdkT0RobnQySWM0NGRKamdYQThPa3gtdEJyVnliR0RPaFU?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings To Watch: Longeveron Inc (LGVN) Reports Q4 2025 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNYmlEVHBFVHl2T2ZCWFFlYWNwVlhJZkl3UWJDNnFUV3FTdjFzWGNHd05hLTZFM1Y2bWRPN096aTRGb2prUUpmNmM2QVRMLXhSQTdrYy1qVVVwMmVXY1BkendfSW1RQUxLUGk0TlNIa3dKNjRPV0EwUXMzZEc5QXh1TzdDdjFVNFE?oc=5", "source_name": "Market source", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron Announces Private Placement of up to $30 Million", "summary": "Longeveron Inc. (NASDAQ: LGVN) announced a private placement targeting up to $30 million in gross proceeds, led by Coastlands Capital and including Janus Henderson Investors. An initial $15 million will extend the company's cash runway into Q4 2026, past the anticipated Q3 2026 t", "url": "https://www.globenewswire.com/news-release/2026/03/10/3252938/0/en/Longeveron-Announces-Private-Placement-of-up-to-30-Million.html", "source_name": "GlobeNewswire", "published_at": "2026-03-14T23:09:58", "published_display": "14 Mar 2026 23:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A $30 Million Reason to Buy Penny Stock Longeveron Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQc0pkeWVRTy1TMG5jUlZsUk9RQXdWRzN2QzkySTVtQ1NZR2xNN3FSQVoySTdJbWtvQ3NzbVlrenEzV1dXMHR0d1pRb0NScDNGZC00ZVNHNkVnRkNqSU0yX0c3ck1lVHpzcmNadWNVM0ZMcnZ3NU00SG5HbUI5UXlBbG9oa2ttMHdKTlRsemVnU1kxMzdTdVJLc0xtRlBhOHc?oc=5", "source_name": "Barchart.com", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron secures $15M financing, eyes $15M more on trial results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOdjV1Y09XY0pxdUJqbnFORGtBazJXcXVGenEzdWtPZVEyMjV5bFZYd0VkbVdGSzRWMU02c0ZEUERNWm1TclI3bkJaQ0JTc0tUSDF4ZnpaVGZhTkhJckgtRWpEdEFVaFg5aHQ5c1BsTnZtQVhWRFpWcnRUVGZYX1ZucWc3cFM0YUVFQVJRODBUSlVVQVZMVXZTaFJrSHpJSkxiSjFhdTViSFI4RUw2NVB5MmxrX0hscjZDMnJQWg?oc=5", "source_name": "Investing.com", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Longeveron secures $15M now, another $15M tied to HLHS trial milestones", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQbVJoS20tcUhMc2N1aDBYTVp0WnVDOUZ0ZUo4bjFTRlJoODFUY20zdDMxLXZ6LTZEM1ZIRk9ub2NucGhFVDJmOXFmTFFaVXA0dFdieXM5ajJiOUhmSnhnbTh5NERaOVVGTUV1UTFkakVQSkZrQVc5bUpldm4zRzhZdTVmd0VjV29mbXV2Nms4dmFycHJDeU5YX2t2RGhDblBJY3VPNjR4V20?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQSW9mM3I5d1lnaHgzVDlPNFgzSVg3MFNNVmk0N0hLcGh3dko0MF9kWUVzS1phTmdDU1NjUGFZamZZWTBmdnFfanllME9NWmhxd0JiMjJzM3JCQU9SVnY0cEx3T3JnT1pDUlh3Vy0xR1lDem9hZ2ZqdUFXd2UzU1JRbkczUEdHZ1hSRGdTN1JfSHgtLUxQVTBJRjNGbS15Z05pZVd0a25wZl9OX0VjNnp4WHVVOUxxeUVwbTJ1TmdMTzZvcEZVbTkzSDdEUFhvZTdtZC1fb3R2SFZ4ZzQ?oc=5", "source_name": "StockStory", "published_at": "2026-07-15T07:00:00+00:00", "published_display": "15 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 92, "total_relevant": 56, "sentiment_summary": {"positive": 3, "negative": 6, "neutral": 47, "score": 49, "total": 56, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 21.45, "count": 39}, {"event": "earnings", "label": "Earnings", "weight": 7.56, "count": 16}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 0.68, "latest_week": "2026-07-10", "one_week_move": -2.2, "four_week_move": -13.7, "twelve_week_move": -38.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.636158, "market_dynamics_buy_signal": false, "relative_strength": -27.772021, "fair_value_gap": -86.8, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 37.2063, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.2% over one week, -13.7% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 26}, {"label": "Market source", "count": 6}, {"label": "GlobeNewswire", "count": 6}, {"label": "Investing.com Nigeria", "count": 2}, {"label": "The Globe and Mail", "count": 2}, {"label": "MT Newswires", "count": 2}, {"label": "TradingView", "count": 2}, {"label": "simplywall.st", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 47}, {"label": "Industry context", "count": 9}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 39}, {"label": "Earnings", "count": 16}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "47", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.2% over one week, -13.7% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Longeveron (NASDAQ: LGVN) updates CEO severance and equity vesting"}], "updated_at": "2026-07-16T17:06:16.637053+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}